This article has been updated with comments from a conference call.

NEW YORK (GenomeWeb News) – Sequenom President and CEO Harry Stylli and Senior VP of R&D Elizabeth Dragon have had their employment terminated by the firm's board of directors, following an investigation into the mishandling of test data, Sequenom announced after the close of the market Monday.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: co-evolutionary signatures of insect hosts and bacterial symbionts, distinct transcript isoforms of high-grade ovarian cancer, and more.

Adam Rutherford discusses genetic genealogy at the Guardian.

Portions of the US 21st Century Cures Act are raising some safety concerns.

David Dobbs writes at Buzzfeed that genomics has delivered little on its promises.